+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Drug Discovery Outsourcing Market by Workflow (Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening), Therapeutics Area (Anti-Infective, Cardiovascular, Central Nervous System), Type, End-User - Forecast 2024-2030- Product Image
Global Drug Discovery Outsourcing Market by Workflow (Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening), Therapeutics Area (Anti-Infective, Cardiovascular, Central Nervous System), Type, End-User - Forecast 2024-2030- Product Image
Sale

Global Drug Discovery Outsourcing Market by Workflow (Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening), Therapeutics Area (Anti-Infective, Cardiovascular, Central Nervous System), Type, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715771
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Discovery Outsourcing Market size was estimated at USD 4.01 billion in 2023, USD 4.38 billion in 2024, and is expected to grow at a CAGR of 9.39% to reach USD 7.53 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Discovery Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Discovery Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Curia Global, Inc., Dalton Pharma Services, Eurofins DiscoverX Products, Evotec SE, GenScript Biotech Corporation, Jubilant Biosys Ltd., Laboratory Corporation of America Holdings, Merck & Co., Inc., Oncodesign Precision Medicine, PPD Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Workflow
    • Lead Identification & Candidate Optimization
    • Preclinical Development
    • Target Identification & Screening
    • Target Validation & Functional Informatics
  • Therapeutics Area
    • Anti-Infective
    • Cardiovascular
    • Central Nervous System
    • Dermatology
    • Endocrine
    • Gastrointestinal
    • Genitourinary System
    • Hematology
    • Immunomodulation
    • Oncology
    • Ophthalmology
    • Pain & Anesthesia
    • Respiratory System
  • Type
    • Biology Services
    • Chemistry Services
  • End-User
    • Academic Institutes
    • Pharmaceutical & Biotechnology companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Drug Discovery Outsourcing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Discovery Outsourcing Market?
  3. What are the technology trends and regulatory frameworks in the Drug Discovery Outsourcing Market?
  4. What is the market share of the leading vendors in the Drug Discovery Outsourcing Market?
  5. Which modes and strategic moves are suitable for entering the Drug Discovery Outsourcing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug Discovery Outsourcing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
5.1.1.2. Increasing pharmaceutical R&D investment
5.1.1.3. Rising demand for generic drugs and biologic innovation
5.1.2. Restraints
5.1.2.1. Compliance issues while outsourcing
5.1.3. Opportunities
5.1.3.1. Increased focus on personalized medicine
5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
5.1.4. Challenges
5.1.4.1. Stringent government regulations
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug Discovery Outsourcing Market, by Workflow
6.1. Introduction
6.2. Lead Identification & Candidate Optimization
6.3. Preclinical Development
6.4. Target Identification & Screening
6.5. Target Validation & Functional Informatics
7. Drug Discovery Outsourcing Market, by Therapeutics Area
7.1. Introduction
7.2. Anti-Infective
7.3. Cardiovascular
7.4. Central Nervous System
7.5. Dermatology
7.6. Endocrine
7.7. Gastrointestinal
7.8. Genitourinary System
7.9. Hematology
7.10. Immunomodulation
7.11. Oncology
7.12. Ophthalmology
7.13. Pain & Anesthesia
7.14. Respiratory System
8. Drug Discovery Outsourcing Market, by Type
8.1. Introduction
8.2. Biology Services
8.3. Chemistry Services
9. Drug Discovery Outsourcing Market, by End-User
9.1. Introduction
9.2. Academic Institutes
9.3. Pharmaceutical & Biotechnology companies
10. Americas Drug Discovery Outsourcing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Drug Discovery Outsourcing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Drug Discovery Outsourcing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Charles River Laboratories
14.1.2. Curia Global, Inc.
14.1.3. Dalton Pharma Services
14.1.4. Eurofins DiscoverX Products
14.1.5. Evotec SE
14.1.6. GenScript Biotech Corporation
14.1.7. Jubilant Biosys Ltd.
14.1.8. Laboratory Corporation of America Holdings
14.1.9. Merck & Co., Inc.
14.1.10. Oncodesign Precision Medicine
14.1.11. PPD Inc.
14.1.12. Thermo Fisher Scientific Inc.
14.1.13. WuXi AppTec
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
FIGURE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
FIGURE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2030 (%)
FIGURE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 6. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENITOURINARY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESPIRATORY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 44. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 45. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 66. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 67. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 70. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 71. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 78. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 79. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 103. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 115. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 116. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 119. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 120. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 123. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 124. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 127. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 128. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 131. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 132. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 139. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 140. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 151. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 152. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 155. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 156. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 159. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 160. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 175. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 176. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 187. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 188. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 199. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 200. DRUG DISCOVERY OUTSOURCING MARKET LICENSE & PRICING

Companies Mentioned

  • Charles River Laboratories
  • Curia Global, Inc.
  • Dalton Pharma Services
  • Eurofins DiscoverX Products
  • Evotec SE
  • GenScript Biotech Corporation
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Oncodesign Precision Medicine
  • PPD Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.53 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Preclinical CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 171 Pages
  • Global
From
Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030 - Product Image

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical), By Service Type (Laboratory, Regulatory/Medical Affairs), By Region (North America, Asia Pacific), And Segment Forecasts, 2023-2030

  • Report
  • 175 Pages
  • Global
From
Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2023-2030 - Product Image

Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2023-2030

  • Report
  • 193 Pages
  • Global
From
Preclinical CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Preclinical CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 147 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Services, Ultrasound Imaging), By Application (Research and Development, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Services, Ultrasound Imaging), By Application (Research and Development, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.